Capital Analysts, LLC Alvotech Transaction History
Capital Analysts, LLC
- $3.43 Billion
- Q3 2025
A detailed history of Capital Analysts, LLC transactions in Alvotech stock. As of the latest transaction made, Capital Analysts, LLC holds 932 shares of ALVO stock, worth $5,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
932
Previous 1,791
47.96%
Holding current value
$5,116
Previous $16,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALVO
# of Institutions
66Shares Held
15MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.35MShares$23.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$14.9 Million12.58% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$8.58 Million0.33% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.45MShares$7.98 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$7.24 Million12.0% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $1.37B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...